Esther Redín

687 total citations
19 papers, 337 citations indexed

About

Esther Redín is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Esther Redín has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Esther Redín's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Esther Redín is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Esther Redín collaborates with scholars based in Spain, United States and Germany. Esther Redín's co-authors include Alfonso Calvo, Luis M. Montuenga, Francisco Expósito, Miriam Redrado, Diego Serrano, Irati Garmendia, María Villalba, Karmele Valencia, Charles M. Rudin and Àlvaro Quintanal-Villalonga and has published in prestigious journals such as Scientific Reports, Cancer Letters and Journal of Hematology & Oncology.

In The Last Decade

Esther Redín

19 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esther Redín Spain	12	175	128	111	72	70	19	337
Jittiporn Chaisaingmongkol Thailand	10	227 1.3×	138 1.1×	134 1.2×	134 1.9×	52 0.7×	13	419
Chen-Yu Hu China	12	214 1.2×	85 0.7×	126 1.1×	55 0.8×	41 0.6×	19	371
Rebecca Pharaon United States	10	181 1.0×	210 1.6×	82 0.7×	65 0.9×	166 2.4×	27	408
Elena Menietti Switzerland	5	174 1.0×	219 1.7×	81 0.7×	69 1.0×	38 0.5×	7	357
Katriana Nugent United States	8	297 1.7×	202 1.6×	95 0.9×	109 1.5×	61 0.9×	14	460
Wenyi Fan United States	9	180 1.0×	163 1.3×	87 0.8×	70 1.0×	63 0.9×	27	340
Francesca Sparano Italy	9	113 0.6×	219 1.7×	65 0.6×	78 1.1×	103 1.5×	19	369
Ludimila Cavalcante United States	12	148 0.8×	238 1.9×	60 0.5×	82 1.1×	78 1.1×	54	423
Marion Jacquin France	8	156 0.9×	161 1.3×	68 0.6×	128 1.8×	56 0.8×	16	340
Rico D. Bense Netherlands	8	177 1.0×	298 2.3×	141 1.3×	153 2.1×	166 2.4×	9	508

Countries citing papers authored by Esther Redín

Since Specialization

Citations

This map shows the geographic impact of Esther Redín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Redín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Redín more than expected).

Fields of papers citing papers by Esther Redín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Redín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Redín. The network helps show where Esther Redín may publish in the future.

Co-authorship network of co-authors of Esther Redín

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Redín. A scholar is included among the top collaborators of Esther Redín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Redín. Esther Redín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wang, Zhanyu, Nan Sun, Jie He, Esther Redín, & Charles M. Rudin. (2025). Molecular Subtypes of Neuroendocrine Carcinoma: From Chaos to Consensus. Annual Review of Pathology Mechanisms of Disease. 21(1). 107–133. 1 indexed citations

Redín, Esther, Yingqian A. Zhan, Hong Zhong, et al.. (2024). SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing. Journal of Hematology & Oncology. 17(1). 58–58. 12 indexed citations

Redín, Esther, Àlvaro Quintanal-Villalonga, & Charles M. Rudin. (2024). Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity. Trends in cancer. 10(10). 935–946. 15 indexed citations

Arozarena, Imanol, Diego Serrano, Esther Redín, et al.. (2023). Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers. 15(12). 3076–3076. 11 indexed citations

Torres, Fernando, Aldo Ummarino, Esther Redín, et al.. (2022). Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines. 10(7). 1590–1590. 15 indexed citations

Garmendia, Irati, Esther Redín, Luis M. Montuenga, & Alfonso Calvo. (2022). YES1: A Novel Therapeutic Target and Biomarker in Cancer. Molecular Cancer Therapeutics. 21(9). 1371–1380. 32 indexed citations

Robles‐Valero, Javier, Myriam Cuadrado, L. Francisco Lorenzo‐Martín, et al.. (2022). Characterization of the spectrum of trivalent VAV1 ‐mutation‐driven tumours using a gene‐edited mouse model. Molecular Oncology. 16(19). 3533–3553. 3 indexed citations

Redín, Esther, Eva M. Garrido‐Martín, Karmele Valencia, et al.. (2022). YES1 Is a Druggable Oncogenic Target in SCLC. Journal of Thoracic Oncology. 17(12). 1387–1403. 17 indexed citations

Palanca-Ballester, Cora, Aitor Rodríguez‐Casanova, Susana Torres‐Martínez, et al.. (2021). Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers. 13(12). 3016–3016. 55 indexed citations

10.

Esteban, Emilio, Francisco Expósito, Guillermo Crespo, et al.. (2021). Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers. 13(11). 2849–2849. 13 indexed citations

11.

Redín, Esther, Alfonso Calvo, Fernando López, et al.. (2021). Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. Cancers. 13(9). 2079–2079. 8 indexed citations

12.

Redín, Esther, Irati Garmendia, Teresa Lozano, et al.. (2021). SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for ImmunoTherapy of Cancer. 9(3). e001496–e001496. 51 indexed citations

13.

Valencia, Karmele, Cristina Sainz, Cristina Bértolo, et al.. (2021). Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma. Disease Models & Mechanisms. 15(1). 5 indexed citations

14.

Llópiz, Diana, Marta Ruiz, Leyre Silva, et al.. (2020). Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy. Cancer Letters. 499. 279–289. 8 indexed citations

15.

Redín, Esther, María Villalba, Francisco Expósito, et al.. (2019). P2.03-38 Identification of a Novel Synthetic Lethal Vulnerability in Non-Small Cell Lung Cancer by Co-Targeting TMPRSS4 and DDR1. Journal of Thoracic Oncology. 14(10). S698–S699. 1 indexed citations

16.

Expósito, Francisco, María Villalba, Miriam Redrado, et al.. (2019). Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery. Cancer Letters. 453. 21–33. 27 indexed citations

17.

Villalba, María, Esther Redín, Francisco Expósito, et al.. (2019). Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1. Scientific Reports. 9(1). 15400–15400. 16 indexed citations

18.

Expósito, Francisco, María Villalba, María J. Pajares, et al.. (2018). P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC. Journal of Thoracic Oncology. 13(10). S521–S521. 2 indexed citations

19.

Bleau, Anne‐Marie, Miriam Redrado, Estanislao Nistal‐Villán, et al.. (2017). miR-146a targets c-met and abolishes colorectal cancer liver metastasis. Cancer Letters. 414. 257–267. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact